University of Salamanca

The host of this seminar is Josep-Maria Ribera.

Dr Alberto Orfao is Full Professor in the Department of Medicine at the University of Salamanca and one of the world’s foremost authorities in flow cytometry, immunophenotyping, and the molecular characterization of hematological malignancies. He serves as Director of the Cancer Research Foundation (FICUS), Deputy Director of the Cancer Research Center (CIC, University of Salamanca– CSIC), and head of the Cytometry and Cell Sorting Services. He is also Scientific Director of the Spanish National DNA Bank and the Castilla y León Tumor Biobank Network, reflecting his central role in advancing large-scale biomedical research infrastructures in Spain and beyond. Over his career, Dr Orfao has transformed the use of multiparameter flow cytometry in the diagnosis and monitoring of leukemias, lymphomas, and other hematologic disorders, establishing new international standards for minimal residual disease detection and molecular diagnostics that have been adopted worldwide. He has coordinated multiple European consortia and networks, including pivotal projects in the EuroFlow and EuroClonality consortia, which set the benchmark for harmonized diagnostic and monitoring approaches in clinical hematology. Dr Orfao has authored more than 1,300 publications, including over 850 peer-reviewed international articles, and holds 74 patents. His work has accumulated tens of thousands of citations, earning him an h-index exceeding 100 and recognition as one of the most highly cited biomedical researchers in the field. Beyond his scientific productivity, he is widely respected as a mentor and educator, having trained generations of hematologists and biomedical scientists in advanced cytometry and translational diagnostics. His many honors include leadership roles in the International Clinical Cytometry Society and recognition from European hematology and oncology organizations for his groundbreaking contributions to laboratory diagnostics and precision medicine. Through his sustained innovation, global collaborations, and institutional leadership, Dr Orfao has helped reshape the landscape of molecular diagnostics in blood cancers, bridging cutting-edge technology with clinical application. His career exemplifies scientific excellence with translational impact, making him a cornerstone figure in modern hematology and a highly influential contributor to the international research community.

IJC Auditorium + Online
Registration here